ISRG Trading Analysis - 10/23/2026 04:46 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Intuitive Surgical (ISRG) that may frame the data below:

• ISRG reported continued strong adoption of its da Vinci robotic surgery systems in recent quarters, with procedure volumes trending above pre-pandemic levels.
• Healthcare capital equipment spending has shown resilience despite elevated interest rates, supporting ISRG's recurring instrument revenue model.
• No specific near-term earnings date was flagged in the embedded data, but fiscal year end is listed as 2025-12-01, with historical Q3 reports typically in October.
• Regulatory clearance for new robotic indications remains a recurring catalyst for upside surprises.
• Broad med-tech sentiment has been constructive, though valuation compression in growth names is a persistent macro concern.

Context: The constructive procedural growth narrative aligns with the bullish options sentiment in the embedded data, though the embedded technicals show elevated RSI that tempers immediate upside conviction.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ISRG (as of 2026-10-23):

• Trailing P/E: 52.30; Trailing EPS: $8.37
• Market Cap: $159,784,106,620.00; Shares Outstanding: 353,278,000.00
• Dividend Yield: 0.00% (no dividend rate or ex-date provided)
• Beta: 1.11 (moderately above market volatility)
• 52-Week High: $603.88; 52-Week Low: $328.57 (current price $452.12 is ~40% above low, ~25% below high)
• Institutional Ownership: 61.61%
• Average Volume: 2,187,000.00; Historical Volatility: 24.95%
• PEG Ratio, Forward P/E, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, Total Revenue: Not provided (null)
• Analyst Consensus / Target Mean Price: Not provided (null)

Fundamental strengths: Large-cap med-tech with meaningful institutional sponsorship (61.61%) and positive EPS. Concerns: Rich trailing P/E of 52.30 with no margin or growth data to justify premium; no dividend. Fundamentals show a profitable but highly valued name; this diverges from the sharp recent price run (close $452.12 vs SMA50 $396.16) where momentum outpaces the static valuation snapshot.

Current Market Position

Current price per indicators: $452.12. Daily history shows close on 2026-10-23 at $452.12 (open $443.65, high $458.45, low $442.56, volume 2,411,560). Prior day close (2026-10-22) was $443.27 with high $443.83.

Minute bars (2026-10-22 09:30 to 2026-10-23 15:55): First bar open $430.75, close $428.46; by 2026-10-23 15:55 last bar close $452.36 after intraday high $453.20. Momentum over the two sessions is upward, with volume expanding on 2026-10-23 (2.41M vs 20d avg 1.52M).

Technical Analysis

SMA alignment: Price > SMA5 > SMA20 > SMA50 (bullish stack, no bearish crossover). RSI 77.19 indicates overbought momentum. MACD (13.60) above signal (10.88), histogram positive 2.72 = bullish. Bollinger: price $452.12 above upper band $449.96 (expansion, statistically stretched). 30d range: price near top (high $458.45, low $368.85; current ~88% of range).

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-23 16:45) via True Sentiment methodology (Delta 40-60 only):

Call Dollar Volume: $2,820,330.00 (68.60%) Put Dollar Volume: $1,292,340.00 (31.40%) Total: $4,112,670.00

• Call Contracts: 1,194 | Put Contracts: 629
• Call Trades: 72 | Put Trades: 39
• Sentiment: Bullish
• Total Options Analyzed: 2,408 | True Sentiment Options: 111 (4.60% filter)

Pure directional conviction skews bullish (68.6% call dollar vol). Near-term expectation: continued upward bias. Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" with advice to wait for alignment, despite sentiment bullish and technicals showing no clear direction per that module (though embedded technicals are objectively bullish).

Key Price Levels (Observational Only)